Golden Cup Balm
Golden Cup Balm is in semi-solid dosage form, a yellow ointment with predominantly wintergreen odor.
There are three active ingredients, Camphor is a stimulant, rubefacient, antipruritic and feebly antiseptic. When in combination with other ingredient like menthol, methyl salicylate, it becomes ideal for neuralgia and other painful areas. Menthol dilates the blood vessels causing a sensation of coldness, followed by an analgesic effect. Menthol also acts as a penetration enhancer, increasing the penetration of drugs when applied on the skin, to give a faster onset of action. And methyl salicylate is a salicylic acid derivative. Salicylates inhibit cyclooxygenase, thereby reducing the formation of prostaglandins, and cause platelet dysfunction Methyl salicylate is used topically as a counterirritant. Upon application, it is absorbed through the skin and is applied for the relief of pain in rheumatic conditions and painful muscle or joints.
Golden Cup Balm is used for fast and effective relief from fatigue, muscular pain, sprains, nausea, dizziness, nasal congestion, insect bites, stings, nettle rash. Apply liberally to affected area not more than 3 to 4 times daily, topically on affected area for relief of symptoms.
Golden Cup Balm contains Methyl Salicylate, Menthol and Camphor as active ingredients and therefore patients with the history of hypersensitive to these ingredients should not use this product. Golden Cup Balm is for external use only and should be avoided using this product on open wounds, damaged skin, mucous membrane, and eyes. It is not advisable to use this product on children under 3 years old.
For pregnancy and lactation, no significant problems have been reported upon topically application of this type of products.
Related News
-
News The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes
For the pharmaceutical industry, outsourcing drug development, manufacturing, and research operations to contract organisations is not just a passing trend – increasingly, the partnership between drug sponsor and drug vendor is one of vital impor... -
News A Day in the Life of a President and Chief Scientific Officer
We are continuing to get to know the people working day-to-day behind the pharma companies shaping the industry, the ones who keep the wheels turning and ultimately bring better healthcare to the population; we are talking to the individuals at the hea... -
News Special Edition Women in Pharma: Women’s health and the pharmaceutical industry
International Women’s Day is an annual celebration of women around the world every March 8. March also marks Women’s History Month. This March, our Women in Pharma series takes a look at how women’s healthcare has developed, and the r... -
News LEAP-ing into the future of pharma – the CPHI Middle East Vision
On March 6, 2024, the CPHI team hosted the Future of Pharma Forum at LEAP 2024, Saudi Arabia’s premier destination for tech leaders and innovators to meet and collaborate. -
News Informa Markets International Women’s Day Panel Discussion
On March 7, 2024, the Informa Markets Amsterdam office hosted an International Women’s Day Breakfast and Panel Discussion to celebrate the women who drive the B2B events industry forward, including members of the CPHI team. -
News CPHI Online Webinar Series – Innovative Strategies for B2B Pharma Marketeers
On February 20, 2024, CPHI Online hosted a webinar on Innovative Strategies for B2B Pharma Marketeers. Featuring expert speakers from across the pharmaceutical value chain, this webinar delves into how B2B pharma marketeers can create better content to... -
News 5 African American Pharmaceutical Pioneers: Honouring Black History Month
In recognition of February as Black History Month in the United States, we cover the lives and works of five pioneering African American pharmaceutical professionals who have contributed significantly to the world of pharmaceuticals and drug devel... -
News What the Novo Holdings and Catalent deal means for pharma outsourcing
On February 5, 2024, Novo Holdings announced their intention to acquire pharma and biotech CDMO Catalent at US$16.5 billion. Read more about what this means for the pharmaceutical industry as a whole, from drugmakers to their partners in manufacturing....
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance